Laboratory Methods in Pediatric Endocrinology

Pediatric Endocrinology

Volumn , Issue , 2008, Pages 855-867

  Rapaport, Robert ^a   Grant, Russell ^b   Hyman, Sharon J ^a   Stene, Mark ^c  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LABORATORY CORPORATION OF AMERICA   (United States)

^c QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882468108     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-141604090-3.50026-0     Document Type: Chapter

References (65)

1. College of American Pathologists (2006). Surveys 2006 K/KN-C. Ligand [volume]:1-33.
2. Klipp J Lab Industry Strategic Outlook 2005. Market Trends and Analysis 2005, 1-222.
3. Kilpatrick ES, Holding S Use of computer terminals on wards to access emergency test results: A retrospective audit. BMJ 2001, 322:1101-1103.
4. Kempers MJE, Lanting CI, van Heijst AFJ, van Trotsenburg ASP, Wiedijk BM, de Vijlder JJM, et al. Neonatal screening for congenital hypothyroidisms based on thyroxine, thyrotropin and thyroxine binding globulin measurements: Potentials and pitfalls. J Clin Endocrinol Metab 2006, 91:3370-3376.
5. Albertsson-Wikland K, Rosberg S, Lannering B, Dunkel L, Stelstam G, Norjavaara E Twenty-four-hour profiles of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol levels: A semilongitudinal study throughout puberty in healthy boys. J Clin Endocrinol Metab 1997, 82:541-549.
6. Albertsson-Wikland K, Rosberg S Reproducibility of 24-hour growth hormone profiles in children. Acta Endocrinol (Copenh) 1992, 125:109-112.
7. Cacciari E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, et al. Pitfalls in diagnosing impaired growth hormone (GH) secretion: Retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1992, 74:1284-1289.
8. Flower L, Ahuja RH, Mohamed-Ali V Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-a and leptin. Cytokine 2000, 12(11):1712-1716.
9. Wenk RE Mechanism of interference by hemolysis in immunoassays and requirements for sample quality. Clinical Chemistry 1998, 44(12):2554.
10. Binkley N, Krueger D, Cowgill CS, Plum L, Lake E, Hansen KE, et al. Assay variation confounds the diagnosis of hypovitaminosis D: A call for standardization. J Clin Endocrinol 2004, 89:3152-3157.
11. Bangham DR Reference materials and standardization. The principles of competitive protein binding assays 1983, 85-106. John Wiley and Sons, New York. Second edition. W.D. Odell, P. Franchimont (Eds.).
12. Rafferty B, Das RG Comparison of pituitary and recombinant human thyroid stimulating hormone (rhTSH) in a multicenter collaborative study: Establishment of the first world health organization reference reagent for rhTSH. Clinical Chemistry 1999, 45:2207-2215.
13. Spencer CA, Bergoglio M, Kazarosyan M, Fatemi S, LoPresti JS Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with thyroid carcinomas. J Clin Endocrinol Metab 2005, 90:5566-5575.
14. Sasse EA, Doumas BT, Miller WG, D'Orazio PD, Eckfeldt JH, Evans SA, et al. How to define and determine reference intervals in the clinical laboratory. NCCLS 2000, 20(13):1-37.
15. Linnet K Nonparametric estimation of reference intervals by simple and bootstrap-based procedures. Clinical Chemistry 2000, 46(6):867-869.
16. Sacks SS Analytical commentary: Are routine testosterone assays good enough?. Clin Biochem Rev 2005, 26:43-45.
17. Lashansky G, Saenger P, Fishman K, Gautier T, Mayes D, Berg G, et al. Normative data for adrenal steroidogenesis in a healthy pediatric population: Age- and sex-related changes after adrenocorticotropin stimulation. J Clin Endocrinol Metab 1991, 73:674-686.
18. Biller BMK, Samuels MH, Zagar A, Cook DM, Arafah BM, Bonert V, et al. Sensitivity and specificity of six test for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab 2002, 87:2067-2079.
19. Shah VP, Midha KK, Dighe S, McGilveray IJ, Skelly JP, Yacobi A, et al. Analytical methods validation: Bioavailability, bioequivalence and pharmacokinetic studies. Pharmaceutical Research 1992, 9(4):588-592.
20. Grant RP, Curtin W, Morr M, Chandler W (2007). Validation strategy for TFC-LC-MS/MS assays used in endogenous analyte quantification for clinical diagnostics. Clinical Chemistry (in press).
21. Bland JM, Altman DG Statistic methods for assessing agreement between two methods of clinical measurement. The Lancet 1986, 307-311. [volume].
22. Zweig MH, Campbell G Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clinical Chemistry 1993, 39:561-577.
23. Wide L Non competitive versus competitive binding assays. The principles of competititve protein-binding assays 1983, 243-254. John Wiley & Sons, New York. Second edition. W.D. O'Dell, P. Franchimont (Eds.).
24. Kricka LJ Human anti-animal antibody interferences in immunological assays. Clinical Chemistry 1999, 45(7):942-956.
25. Ford A Move to integrated analyzers well underway. CAP Today 2006, 14-48. [volume].
26. Minutti CZ, Lacey JM, Magera MJ, et al. Steroid profiling by tandem mass spectrometry improves the positive predictive value of newborn screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004, 89(8):3687-3693.
27. Lacey JM, Magera MJ, Di Bussolo JM, Tortorelli S, Hahn S, Rinaldo P, et al. (2006). Rapid determination of steroids for newborn screening for congenital adrenal hyperplasia (CAH) by turbulent flow liquid chromatography tandem mass spectrometry. ASMS [volume:pages].
28. Taylor RL, Machacek D, Singh RJ Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clinical Chemistry 2002, 48(9):1511-1519.
29. Kushnir MM, Rockwood AL, Nelson GJ, Terry AH, Meikle AW Liquid chromatography-tandem mass spectrometry analysis of urinary free cortisol. Clinical Chemistry 2003, 49(6/1):965-967.
30. Nelson RE, Grebe SK, OKane DJ, Singh RJ Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone. Clinical Chemistry 2004, 50(2):373-384.
31. Wagner A, Kallal T, Curtin B, Chandler DW, Grant RP (2004). LC-MS/MS analysis of steroids for clinical evaluation of endocrine disorders. ASMS [volume:pages].
32. Clarke NJ, Goldman M (2005). Clinical applications of HTLC-MS/MS in the very high-throughput diagnostic environment. ASMS [volume:pages].
33. Morr M, Wagner A, Patel M, Grant RP (2006). Quantitative LC-MS/MS analysis of endogenous biomarkers for clinical diagnosis in endocrinology. ASMS [volume:pages].
34. Grant RP, Morr M, Wagner A (2006). Evaluation of a multiplexed enhanced pressure pumping system for clinical diagnosis. ASMS [volume:pages].
35. Wagner A, Morr M, Grant RP (2006). Ultra low level quantitation of endogenous biomarkers. Bioanalytical Land of Lakes [volume:pages].
36. College of American Pathologists (2006). Surveys 2006 Y-C. Ligand [volume]:1-18.
37. Bonini P, Plebani M, Ceriotti F, Rubboli F Errors in laboratory medicine. Clinical Chemistry 2002, 48:691-698.
38. Lynch J (2006). personal communication, Jane Lynch, M.D.
39. Tomlinson C, Wallace AM, Ahmed SF Erroneous testosterone assay causing diagnostic confusion in a newborn infant with intersex anomalies. Acta Paediatr 2004, 93:1004-1006.
40. Stene M, Panagiotis N, Tuck ML, Sowers JR, Mayes D, Berg G Plasma norepinephrine levels are influenced by sodium intake, glucocorticoid administration and circadian changes in normal man. J Clin Endocrinol Metab 1980, 51:1340-1345.
41. Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone and estradiol secretion before the onset of female puberty in short children. J Clin Endocrinol Metab 2000, 85:1074-1080.
42. Bjornerem A, Straume B, Oian P, Berntsen GKR Seasonal variation of estradiol, follicle stimulating hormone and dehydroepiandrosterone sulfate in women and men. J Clin Endocrinol Metab 2006, 91:3798-3802.
43. Dorgan JF, Hunsberger SA, McMahon RP, Kwiterovich PO, Lauer RM, Van Horn L, et al. Diet and sex hormones in girls:findings from a randomized controlled clinical trial. J Natl Cancer Inst 2003, 95:132-141.
44. Jones JC, Carter GD, MacGregor GA Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone. Ann Clin Biochem 1981, 18(1):54-59.
45. Sadee W, Finn AM, Schmiedek P, Baethmann A Aldosterone plasma radioimmunoassay interference by a spirolactone metabolite steroids 1975, 25(3):301-311.
46. Uwaifo GI, Remaley AT, Stene M, Reynolds JC, Yen PM, Snider RH, et al. A case of spurious hypercalcitoninemia: A cautionary tale on the use of plasma calcitonin assays in the screening of patients with thyroid nodules for neoplasia. J Endocrinol Invest 2002, 25:197.
47. Leboeuf R, Langlois M, Martin M, Ahnadi C, Fink GD Clinical case seminar "hook effect" in calcitonin immunoradiometric assay in patients with metastatic medullary thyroid carcinoma: Case report and review of the literature. J Clin Endocrinol Metab 2006, 91:361-364.
48. Sinicco A, Raiteri R, Rossati A, Savarino A, Di Perri GE Favirenz interference in estradiol ELISA assay. Clin Chem 2000, 46(5):734-735.
49. Tejada F, Cremades A, Monserrat F, Penafiel R Interference of the antihormone RU486 in the determination of testosterone and estradiol by enzyme-immunoassay. Clin Chim Acta 1998, 275(1):63-69.
50. Markkanen H, Pekkarinen T, Valimaki MJ, Alfthan H, Kauppinen-Makelin R, Sane T, et al. (year). Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and healthy controls. Clinical Chemistry 52:468-473.
51. Jansson C, Boguszewski C, Rosberg S, Carlsson L, Albertsson-Wikland K Growth hormone (GH) assays: Influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clinical Chemistry 1997, 43(6):950-956.
52. Blum WF, Brier BH Radioimmunoassays for IGFs and IGFBPs. Growth Regulation 1994, 4(1):11-19.
53. Owen WE, Roberts WL Cross-reactivity of three recombinant insulin analogs with five commercial insulin assays. Clinical Chemistry 2004, 50:257-259.
54. Boudou P, Ibrahim F, Cormier C, Chabas A, Sarfati E, Souberbielle J Third- or second-generation parathyroid hormone assays: A remaining debate in the diagnosis of primary hyperparathyroidism. J Clin Endocrinol Metab 2005, 90:6370-6372.
55. Cantor T, Yang Z, Caraiani N, Ilamathi E (year). Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: Implications for treatment decisions. Clinical Chemistry 52:1771-1776.
56. Gibney J, Smith TP, McKenna TJ The impact on clinical practice of routine screening for macroprolactin. J Clin Endorinol 2005, 90:3927-3932.
57. Key TJ, Moore JW Interference of sex-hormone binding globulin in a no-extraction double-antibody radioimmunoassay for estradiol. Clin Chem 1988, 34(6):1357-1358.
58. Sapin R, d'Herbomez M, Schlienger JL, Wemeau JL Anti-thyrotropin antibody interference in thyrotropin assays. Clinical Chemistry 1998, 44(12):2557-2559.
59. Wartofsky L, Dicker RA Controversy in clinical endocrinology: The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005, 90:5483-5488.
60. Surks ML, Goswami G, Daniels GH Controversy in clinical endocrinology: The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 2005, 90:5489-5496.
61. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK HPLC method for 25-hydroxyvitamin D measurement: Comparison with contemporary assays. Clinical Chemistry 2006, 52:1120-1126.
62. Singh RJ, Taylor RL, Satyanarayana GS, Grebe SKG C-3 epimers can account for a significant proportion of total circulating 25-hydroxyvitamin D in infants, complicating accurate measurement and interpretation of vitamin D status. J Clin Endocrinol 2006, 91:3055-3061.
63. Advia Centaur 111751 Rev. J, 2004-03.
64. American Society for Mass Spectrometry (1998). What is mass spectrometry, Third edition. [city: publisher] 22.
65. Fuqua JS, Sher ES, Migeon CJ, Berkovitz GD Assay of plasma testosterone during the first sex months of life: Importance of chromatographic purification of steroids. Clinical Chemistry 1995, 41:1146-1149.